Angle PLC
LSE:AGL
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Altria Group Inc
NYSE:MO
|
Tobacco
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Medical Properties Trust Inc
NYSE:MPW
|
Real Estate
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.25
31.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Altria Group Inc
NYSE:MO
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Medical Properties Trust Inc
NYSE:MPW
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US |
This alert will be permanently deleted.
Angle PLC
Accounts Receivables
Angle PLC
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Angle PLC
LSE:AGL
|
Accounts Receivables
ÂŁ1.9m
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Smith & Nephew PLC
LSE:SN
|
Accounts Receivables
$1.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
||
LivaNova PLC
NASDAQ:LIVN
|
Accounts Receivables
$197.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
15%
|
||
EKF Diagnostics Holdings PLC
LSE:EKF
|
Accounts Receivables
ÂŁ6.6m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
||
Creo Medical Group PLC
LSE:CREO
|
Accounts Receivables
ÂŁ9.9m
|
CAGR 3-Years
13%
|
CAGR 5-Years
65%
|
CAGR 10-Years
N/A
|
||
B
|
Belluscura PLC
LSE:BELL
|
Accounts Receivables
$305.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
Angle PLC
Glance View
ANGLE Plc operates as a holding company, through its subsidiaries engages in providing products in cancer diagnostics and foetal health. The company is headquartered in Guildford, Surrey and currently employs 102 full-time employees. The company went IPO on 2004-03-17. The Company’s lead product is the Parsortix cell separation system, which captures very rare cells from the blood. This includes circulating tumor cells (CTCs) in cancer patient blood even when there is less than one CTC in one billion healthy cells. The Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The Company’s translational research includes ovarian cancer, breast cancer, prostate cancer and small cell lung cancer.
See Also
What is Angle PLC's Accounts Receivables?
Accounts Receivables
1.9m
GBP
Based on the financial report for Jun 30, 2024, Angle PLC's Accounts Receivables amounts to 1.9m GBP.
What is Angle PLC's Accounts Receivables growth rate?
Accounts Receivables CAGR 3Y
11%
Over the last year, the Accounts Receivables growth was 34%. The average annual Accounts Receivables growth rates for Angle PLC have been 11% over the past three years .